DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Sarah Tabrizi
Sarah Tabrizi
Scientific Advisory Board
Clinical Review Huntington's Disease
Press Release
Director's View: December 2020 Message from the Director And
In This Issue Famous Neurologists Personal Perspectives
Compensation in Preclinical Huntington's Disease: Evidence from the Track-On HD Study
11-Ehdn-Newsletter-Oct2010
A Physician's Guide to the Management of Huntington's Disease
The C9orf72 Expansion Is the Most Frequent Genetic Cause Of
Ehdn-Newsletter-Mar2014
23-Ehdn-Newsletter-Nov2014
Compensation in Preclinical Huntington's Disease: Evidence from the Track-On HD Study
The Genetics Basis of Neurological Disorders
Postgraduate Opportunities 2020 Medicine & Biomedical Sciences
Natural Biological Variation of White Matter Microstructure Is
HDSA's 2018 Research Report Now Available
2008 Chicago, IL
WCHD Abstracts: Poster Programme
Top View
Medicine & Biomedical Sciences
Annual Fellows' Meeting
Patients with Huntington´S Disease Pioneered Human Stereotactic Neurosurgery 70 Years Ago
Evidence from Huntington's Disease
1 Optimal Time to Treat Huntington's Disease Identified Https
How Many People Have Huntington Disease?
The Big Hope for Huntington's
Out of the Darkness: a History of Huntington's Disease in Australia
Personal Statements of New National Clinical Excellence Award Recipients (England and Wales) 2019
1 Measuring Compensation in Neurodegeneration Using MRI
Article Short-Interval Observational Data to Inform Clinical Trial Design In
News from the Hereditary Disease Foundation
Hereditary Disease Foundation H Re Edit Yra F H Nu I of Id Reh Adn Seai Edit Noita Ase Yrta N Y F Nuo and Noita N
Queen Square Alumnus Association
Fronto-Striatal Circuits for Cognitive Flexibility in Far from Onset
Progression Determinants in Huntington Disease
December 2013 Contents HDA Newsletter December 2013
Inbrief 27 Feb 2020
Dementia and Neurodegeneration a Window of Opportunity UCL SCHOOL of LIFE and MEDICAL SCIENCES Creating Knowledge, Achieving Impact PREFACE
17-Ehdn-Newsletter-Nov2012
Overlap Between Age-At-Onset and Disease-Progression Determinants in HD
Queen Square Alumnus Newsletter Issue 8.Pdf
Clinical Study Protocol: HD-YAS Study
Identification of Markers of Disease Onset and Progression In
EHDN Clinical Trials Update
The Presymptomatic Neurodegeneration Initiative (Preni)
Scientific Advisory Board
Lauren Byrne